• Sierra's bet on Gilead castoff pays off, teeing up FDA filing for rival to Incyte-Novartis cancer drug

    4 monthes ago - By Fierce Biotech

    Sierra's bet on Gilead castoff pays off, teeing up FDA filing for rival to Incyte-Novartis cancer drug ntaylor
    Tue, 01/25/2022 - 08:10
    Read more ...